跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dasamia 140 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dasamia 140
Approved
STANDARD
Dasamia 140
Sun Pharma Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cef8dd757ef9c937
Company
Sun Pharma Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
cef8dd757ef9c937
Drug Approval Philippines Name
Dasamia 140
Product Name
Dasamia 140
Registration Number
DR-XY48566
Brand Name
Dasamia 140
Generic Name
Dasatinib
Dosage Form
Film-Coated Tablet
Dosage Strength
140 mg
Manufacturer
Sun Pharma Laboratories Ltd.
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharma-laboratories-ltd
Issuance Date
05 June 2024
Expiry Date
18 January 2028
Pharmacologic Category
Antineoplastic Agent (BCR-ABL Tyrosine Kinase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cef8dd757ef9c937
Type
Standard
Back to Philippines FDA Approvals